Skip to main content

Table 2 Patient characteristics

From: Dose escalation of accelerated hypofractionated three-dimensional conformal radiotherapy (at 3 Gy/fraction) with concurrent vinorelbine and carboplatin chemotherapy in unresectable stage III non-small-cell lung cancer: a phase I trial

Characteristic   No. of patients   Percentage of Patients (%)
   N = 13   
Gender     
  Male 9   69.2
  Female 4   30.8
Age     
  Median   65  
  Range   57-75  
Karnofsky performance status   
  Median   80  
  Range   70-90  
Histology     
  Squamous cell carcinoma 7   53.8
  Adenocarcinoma 6   46.2
Stage     
  IIIA 6   46.2
  IIIB 7   53.8
GTV     
  Median   84.6 cm3  
  Range   22.3-222.5 cm3  
PTV     
  Median   234.9 cm3  
  Range   111.6-369.7 cm3